Cargando…
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study
Elevated pregnancy-associated plasma protein A (PAPP-A) is associated with mortality in acute coronary syndromes. Few studies have assessed PAPP-A in stable coronary artery disease (CAD) and results are conflicting. We assessed the 10-year prognostic relevance of PAPP-A levels in stable CAD. The CLA...
Autores principales: | Nilsson, Erik, Kastrup, Jens, Sajadieh, Ahmad, Boje Jensen, Gorm, Kjøller, Erik, Kolmos, Hans Jørn, Wuopio, Jonas, Nowak, Christoph, Larsson, Anders, Jakobsen, Janus Christian, Winkel, Per, Gluud, Christian, Iversen, Kasper K, Ärnlöv, Johan, Carlsson, Axel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019890/ https://www.ncbi.nlm.nih.gov/pubmed/31963719 http://dx.doi.org/10.3390/jcm9010265 |
Ejemplares similares
-
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial
por: Winkel, Per, et al.
Publicado: (2020) -
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
por: Winkel, Per, et al.
Publicado: (2017) -
10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy
por: Carlsson, Axel C., et al.
Publicado: (2018) -
Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course
por: Winkel, Per, et al.
Publicado: (2018) -
Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)